EUVIMEDEUVIMED entdecken
Open Access

Selective Wee1 Inhibitors Led to Antitumor Activity In Vitro and Correlated with Myelosuppression

Satenig Guler iD, Maria C DiPoto, Alejandro Crespo, Richard Caldwell, Benjamin Doerfel, Nina Grossmann, Kevin Ho, Bayard Huck, Christopher Cv Jones iD, Ruoxi Lan, Djordje Musil, Justin Potnick und 6 weitere

ACS Medicinal Chemistry Letters · 11.05.2023 · 14 (5) · 566-576

DOI: 10.1021/acsmedchemlett.2c00481 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Medicinal Chemistry Letters, online erschienen am 07.04.2023. Verfasst von Satenig Guler und 17 weiteren Autor:innen. Beteiligte Einrichtung: EMD Serono, Billerica, Massachusetts 01821, United States. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Wee1 is a tyrosine kinase that is highly expressed in several cancer types. Wee1 inhibition can lead to suppression of tumor cell proliferation and sensitization of cells to the effects of DNA-damaging agents. AZD1775 is a nonselective Wee1 inhibitor for which myelosuppression has been observed as a dose-limiting toxicity. We have applied structure-based drug design (SBDD) to rapidly generate highly selective Wee1 inhibitors that demonstrate better selectivity than AZD1775 against PLK1, which is known to cause myelosuppression (including thrombocytopenia) when inhibited. While selective Wee1 inhibitors described herein still achieved in vitro antitumor efficacy, thrombocytopenia was still observed in vitro.

Autor:innen und Institutionen

  • EMD Serono, Billerica, Massachusetts 01821, United States.
  • Merck Healthcare KGaA, 64293 Darmstadt, Germany.

ORCID-Profile: Satenig Guler, Christopher Cv Jones

Zitieren

APA

Guler, S., DiPoto, M. C., Crespo, A., Caldwell, R., Doerfel, B., Grossmann, N., Ho, K., Huck, B., Jones, C. C., Lan, R., Musil, D., Potnick, J., Schilke, H., Sherer, B., Simon, S., Sirrenberg, C., Zhang, Z., & Liu-Bujalski, L. (2023). Selective Wee1 Inhibitors Led to Antitumor Activity In Vitro and Correlated with Myelosuppression. ACS Medicinal Chemistry Letters, 14(5), 566-576. https://doi.org/10.1021/acsmedchemlett.2c00481

Vancouver

Guler S, DiPoto MC, Crespo A, Caldwell R, Doerfel B, Grossmann N, et al. Selective Wee1 Inhibitors Led to Antitumor Activity In Vitro and Correlated with Myelosuppression. ACS Medicinal Chemistry Letters. 2023;14(5):566-576. doi:10.1021/acsmedchemlett.2c00481

BibTeX
@article{Guler2023,
  author = {Guler, Satenig and DiPoto, Maria C and Crespo, Alejandro and Caldwell, Richard and Doerfel, Benjamin and Grossmann, Nina and Ho, Kevin and Huck, Bayard and Jones, Christopher Cv and Lan, Ruoxi and Musil, Djordje and Potnick, Justin and Schilke, Heike and Sherer, Brian and Simon, Stephanie and Sirrenberg, Christian and Zhang, Zhuo and Liu-Bujalski, Lesley},
  title = {Selective Wee1 Inhibitors Led to Antitumor Activity In Vitro and Correlated with Myelosuppression},
  journal = {ACS Medicinal Chemistry Letters},
  year = {2023},
  volume = {14},
  number = {5},
  pages = {566--576},
  doi = {10.1021/acsmedchemlett.2c00481}
}
Kostenlos starten →